Exploitation of antibiotic resistance as a novel drug target: development of a β-lactamase-activated antibacterial prodrug.

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.